Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

The Role of Clonally Expanded CD8 + Non-CAR-T Cells in Neurocognitive and Hypokinetic Movement Disorder after BCMA-Targeting CAR-T Cell Therapy

Blood (2024) 144 (Supplement 1): 7086.

https://doi.org/10.1182/blood-2024-202348

Published: 2024

Journal Articles

Functional Imaging As a Key Diagnostic Tool in the Follow-up of RRMM Patients after CAR-T-Cell Therapy

Sven Schimanski, Hannah Hornburger, Sofie-Katrin Kadel, Anna Marie Ruckdeschel, Florian Eisele, Daniela Schneider, Anke Heidemeier, Andreas Buck, Rudolf Werner, Johannes M Waldschmidt, Paula Tabares, Andreas Beilhack, Johannes Duell, Hermann Einsele, K. Martin Kortüm, Max S. Topp, Leo Rasche

Blood (2023) 142 (Supplement 1): 3372.

https://doi.org/10.1182/blood-2023-188501

Published: 2023

Journal Articles

Pseudoprogression and Sarcoidosis-like Phenomena after CART-Cells and Bispecific Antibodies in Multiple Myeloma

Alexander Leipold, Rudolf Werner, Johannes Duell, Pius Jung, Mara John, Emilia Stanojkovska, Xiang Zhou, Anna Ruckdeschel, Oliver Dietrich, Fabian Imdahl, Tobias Krammer, Andreas Buck, Julia Mersi, Hermann Einsele, K. Martin Kortuem, Antoine-Emmanuel Saliba, Leo Rasche

Blood (2022) 140 (Supplement 1): 10020–10021.

https://doi.org/10.1182/blood-2022-168836

Published: 2022

Journal Articles

Real-World Experience with Minimal Residual Disease Testing with Next Generation Flow Cytometry and Functional Imaging in Multiple Myeloma

David Böckle, MD, Paula Tabares Gaviria, Xiang Zhou, MD, Janin Messerschmidt, MD, Lukas Scheller, Maximilian Johannes Steinhardt, MD, Elena Seebacher, Maria Ulbrich, Anke Heidemeier, MD, Andreas Buck, MD, Hermann Einsele, MD, Andreas Beilhack, MD, Martin Kortuem, MD, Leo Rasche, MD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-140772

Published: 2020

Journal Articles

CXCR4-Targeted Positron Emission Tomography Imaging of Central Nervous System B-Cell Lymphoma

Peter Herhaus, MD, Jana Lipkova, Felicitas Lammer, MD, Julia Slotta-Huspenina, MD, Benedikt Wiestler, MD, Tibor Vag, MD, Stefan Habringer, MD, Igor Yakushev, MD, Constantin Lapa, MD, Tobias Pukrop, MD, Dirk Hellwig, MD, Andreas Buck, MD, Martina Deckert, MD, Hans-Jürgen Wester, PhD, Florian Bassermann, MD PhD, Wolfgang Weber, MD, Markus Schwaiger, MD, Björn Menze, PhD, Ulrich Keller, MD

Blood (2019) 134 (Supplement_1): 2900.

https://doi.org/10.1182/blood-2019-126024

Published: 2019

Journal Articles

CXCR4 PET/CT Scan Is Superior to FDG PET/CT Scan in Accurately Defining Marginal Zone Lymphoma Nodal and Extranodal Involvement

Johannes Duell, MD, Andreas Rosenwald, Franziska Krummenast, MD, Andreas Buck, MD, Hermann Einsele, MD, Max S. Topp, Constantin Lapa, MD

Blood (2018) 132 (Supplement 1): 2881.

https://doi.org/10.1182/blood-2018-99-118339

Published: 2018

Journal Articles

[68Ga]Pentixafor: A Novel PET Tracer for Imaging CXCR4 Status in Patients with Multiple Myeloma

Blood (2014) 124 (21): 2014.

https://doi.org/10.1182/blood.V124.21.2014.2014

Published: 2014

Journal Articles

[18F]FLT Is Superior to [18F]FDG to Early Predict Response to Specific Inhibitors of NPM-ALK-Dependent Pathways In a Human ALCL Xenograft Model

Nicolas Graf, MD, Zhoulei Li, Ken Herrmann, MD, Alexandra Junger, Daniel Weh, Christian Peschel, MD, Markus Schwaiger, MD, Andreas Buck, MD, Tobias Dechow, MD

Blood (2010) 116 (21): 2849.

https://doi.org/10.1182/blood.V116.21.2849.2849

Published: 2010

Journal Articles

Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state

Jürgen den Hollander, Sara Rimpi, Joanne R. Doherty, Martina Rudelius, Andreas Buck, Alexander Hoellein, Marcus Kremer, Nikolas Graf, Markus Scheerer, Mark A. Hall, Andrei Goga, Nikolas von Bubnoff, Justus Duyster, Christian Peschel, John L. Cleveland, Jonas A. Nilsson, Ulrich Keller

Blood (2010) 116 (9): 1498–1505.

https://doi.org/10.1182/blood-2009-11-251074

Published: 2010

Includes: Supplemental data

Journal Articles

Loss of Therapy-Induced Senescence in Myc-Driven Lymphomas Compromises Treatment Outcome In Vivo.

Jan Dörr, Yong Yu, Christoph Loddenkemper, MD, PhD, Ulrich Keller, MD, Andreas Buck, Bernd Dörken, Clemens Schmitt, MD

Blood (2009) 114 (22): 1686.

https://doi.org/10.1182/blood.V114.22.1686.1686

Published: 2009

Journal Articles

Antifungal Therapy with Itraconazole Impairs Rituximab′s Anti-Lymphoma Effect by Inhibiting CD20 Recruitment to Lipid Rafts.

Christian Meyer zum Bueschenfelde, Yvonne Feuerstacke, Philipp Krainz, Ken Herrmann, Andreas Buck, Christian Peschel, MD, Ingo Ringshausen

Blood (2009) 114 (22): 2735.

https://doi.org/10.1182/blood.V114.22.2735.2735

Published: 2009

Journal Articles

Association of Increased Thymidine Uptake Relative to Tumor Cell Proliferation in Low-Grade Follicular Lymphoma and DNA Repair.

Malik E. Juweid, MD, Sergei I. Syrbu, Michelle Bleile, Andreas Buck, Marielle Wondergem, MD, Julie M. Vose, M.D.

Blood (2009) 114 (22): 3236.

https://doi.org/10.1182/blood.V114.22.3236.3236

Published: 2009

Journal Articles

Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

Donald Bunjes, Inga Buchmann, Christian Duncker, Ulrike Seitz, Jörg Kotzerke, Markus Wiesneth, Dagmar Dohr, Martin Stefanic, Andreas Buck, Stefanie V. Harsdorf, Gerhard Glatting, Wolfgang Grimminger, Tunca Karakas, Gerd Munzert, Hartmut Döhner, Lothar Bergmann, Sven N. Reske

Blood (2001) 98 (3): 565–572.

https://doi.org/10.1182/blood.V98.3.565

Published: 2001

NARROW

The Role of Clonally Expanded CD8 + Non-CAR-T Cells in Neurocognitive and Hypokinetic Movement Disorder after BCMA-Targeting CAR-T Cell Therapy

Functional Imaging As a Key Diagnostic Tool in the Follow-up of RRMM Patients after CAR-T-Cell Therapy

Pseudoprogression and Sarcoidosis-like Phenomena after CART-Cells and Bispecific Antibodies in Multiple Myeloma

Real-World Experience with Minimal Residual Disease Testing with Next Generation Flow Cytometry and Functional Imaging in Multiple Myeloma

CXCR4-Targeted Positron Emission Tomography Imaging of Central Nervous System B-Cell Lymphoma

CXCR4 PET/CT Scan Is Superior to FDG PET/CT Scan in Accurately Defining Marginal Zone Lymphoma Nodal and Extranodal Involvement

[68Ga]Pentixafor: A Novel PET Tracer for Imaging CXCR4 Status in Patients with Multiple Myeloma

[18F]FLT Is Superior to [18F]FDG to Early Predict Response to Specific Inhibitors of NPM-ALK-Dependent Pathways In a Human ALCL Xenograft Model

Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state

Loss of Therapy-Induced Senescence in Myc-Driven Lymphomas Compromises Treatment Outcome In Vivo.

Antifungal Therapy with Itraconazole Impairs Rituximab′s Anti-Lymphoma Effect by Inhibiting CD20 Recruitment to Lipid Rafts.

Association of Increased Thymidine Uptake Relative to Tumor Cell Proliferation in Low-Grade Follicular Lymphoma and DNA Repair.

Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only